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Objective" To study the factors leading to wound problems in patients with chronic renal insufficiency (CRI) with 
emphasis on subcutaneous v . deep placement of grafts. 
Methods: The outcomes of patients undergoing an infrainguinal bypass with preoperative CRI (serum creatinine >- 2.0 
mg/dI) were reviewed. Surgical site infection (SSI) was classified as superficial or deep according to the Centres for Disease 
Control standards. 
Results: Forty-two patients underwent a total of 47 infrainguinal bypasses for ischaemic rest pain or tissue loss. The graft 
location was partially or predominantly subcutaneous in 21 limbs (Group I) and 26 grafts were positioned in the anatomic 
or subfascial planes (Group II). In Group L seven early (< 30 days postoperative), one intermediate (4-6 weeks 
postoperative), and one late ( > 6 weeks postoperative) SSI's were found (9/21, 43 %). In three of these patients the graft was 
exposed and two required removal. In contrast, only two early and one intermediate SSI's (3/26, 12%) were noted in Group 
II (p = 0.02). A logistic regression analysis, with twelve possible covariables to wound healing, confirmed the subcutaneous 
location to be the only controllable factor significantly predicting SSI (relative risk = 11.6, p = 0.01). 
Conclusions: The infrainguinal bypass in patients with CRI is associated with a high incidence of wound complications. 
In our retrospective s ries, the presence of a vascular conduit in the subcutaneous plane zoas connected with a higher rate 
of SSL Despite the growing trend toward the use of the in situ bypass, CRI may represent a circumstance where deeply 
placed grafts should be used preferentially. 
Introduction 
Infrainguinal revascularisation has become the treat- 
ment of choice in limb threatening ischaemia. To 
further improve results, attempts have been made to 
identify determinants of perioperative morbidity and 
mortality. In this respect, patients with end-stage renal 
disease (ESRD) have been distinguished as a high-risk 
subgroup. Some authors have considered the many 
comorbid conditions in these patients prohibitive for 
revascularisation and advocate primary amputation 
for lower limb ischaemic ulceration or gangrene. 1 
Despite higher operative morbidity and mortality 
rates, more recent series recommend an approach to 
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ESRD patients imilar to that applied to patients with 
normal renal function. 2-6 
Although most studies focused on ESRD patients, 
increased perioperative morbidity and mortality rates 
have also been shown for infrainguinal revascularisa- 
tion in patients with a milder degree of chronic renal 
insufficiency, s To improve results in the subgroup of 
CRI patients, it is necessary to focus on the individual 
determinants of suboptimal outcome. In several stud- 
ies on patients with ESRD, increased wound complica- 
tion rates have been reported. 3-6 The possible associa- 
tion of the in situ technique with wound problems has 
been suggested in two earlier reports. 6"7 
In our computerised vascular surgery registry an 
alarmingly high incidence of wound infections was 
noted after in situ bypass surgery in CRI patients (6 
out of 16 in the last 3 years), whereas the contempo- 
rar~ annual wound infection rates of our in situ 
bypasses in patients with normal renal function varied 
between 5 and 10%. We therefore reviewed all 
infrainguinal bypass procedures in patients with CRI 
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to find a possible relationship between wound prob- 
lems and the graft location. 
Materials and Methods 
The computerised atabase of the Massachusetts 
General Hospital was examined to identify all patients 
with the diagnostic ode for chronic renal insuffi- 
ciency and the therapeutic ode for a peripheral 
vascular bypass. The records of 129 patients meeting 
these selection criteria between January 1980 and 
March 1993 were reviewed. Chronic renal insuffi- 
ciency (CRI) was defined as a sustained elevation of 
serum creatinine over 2.0 mg/dl, for at least 6 months. 
Patients with a kidney transplantation were also 
included if serum creatinine xceeded 2.0 mg/dl. Only 
infrainguinal bypasses for ischaemic rest pain or tissue 
loss were included and patients with acute ischaemia 
were excluded. Eighty-seven patients were excluded 
from this group: 63 had creatinine levels below 2.0 
mg/dl, in 10 patients the history of renal insufficiency 
was shorter than 6 months, and in 14 patients an extra- 
anatomic bypass was performed. Forty-two patients 
who met our inclusion criteria underwent a total of 47 
infrainguinal bypasses. In these patients the grafts 
were placed either subcutaneously or deep, according 
to the preference of the surgeon. 
Demographic data, including risk factors and asso- 
ciated diseases (diabetes mellitus, tobacco abuse, 
hypertension, hyperlipidaemia, nd cardiac, renal, 
pulmonary, and carotid disease), and the presentation 
of peripheral vascular disease were classified and 
graded according to the suggested standards for 
reports dealing with lower extremity ischaemia by the 
Ad Hoc Committee on Reporting Standards of the 
SVS/NA-ISCVS. 8 Risk factors were graded from 0 
points (risk factors absent) to 3 points (major risk 
factor) and a total risk factor score was calculated by 
adding the grade for each of these eight risk factors. 
Indication, date, duration, and technical details of the 
vascular procedure and outcome at discharge and 
follow-up were all recorded. 
Wound infection was classified as superficial or 
deep Surgical Site Infection (SSI) according to the 
guidelines of the 1992 standards of the Centres for 
Disease Control. 9A superficial SSI involves skin and 
subcutaneous ti sue only and is identified by one of 
the following criteria: purulent drainage from the 
incision, organisms isolated from an aseptically 
obtained wound culture, or (unless culture is neg- 
ative) if the superficial incision is deliberately opened 
and at least one of the following signs/symptoms is 
found: pain/tenderness, localised swelling, redness, 
heat. A deep SSI affects the deep tissue layers of the 
incision (fascia/muscle) and needs one of the follow- 
ing criteria: purulent drainage or any other evidence 
of abscess involving the deep incision, or (unless 
culture is negative) deliberate opening of the deep 
incision in the presence of pain/tenderness or fever 
above 38°C. Only those infections that occur within 30 
days of the incision are designated SSI by the CDC- 
standards. However, if a permanently placed, non- 
human-derived implant is used, any infection that 
appears to be related to the operative procedure is also 
classified SSI. To further specify the time frame, we 
distinguished the time limits of the 1991 United 
Kingdom Surgical Infection Study Group1°: early 
(within 30 days), intermediate (1-3 months), and late 
(after 3 months postoperatively). 
To study the role of the graft location, bypasses were 
classified into two groups. Group I included grafts 
that were placed partially or predominantly subcuta- 
neous and grafts positioned in the anatomic or 
subfascial planes were enrolled in Group II. 
Continuous variables were analysed with the 
Mann-Whitney test and discrete variables with the 
Fisher-exact test. To more accurately define the inde- 
pendent effect of graft location on wound infection, 
twelve possible covariables to wound healing were 
entered in a logistic regression analysis using the 
Statistical Package for Social Sciences (Microsoft 
SPSS/PC+, V4.0). Of the five patients in whom 
bilateral procedures were performed only data on the 
first operation were used in this multiple regression 
model. Patency, salvage, and survival rates were 
assessed by life table analysis according to Kaplan and 
Meier. n Expected survival was calculated for a similar 
group of individuals from the general population, 
matched for age and gender. All tests were two-tailed 
and p < 0.05 was considered statistically significant. 
Results 
There were 28 male and 14 female patients with a 
median age of 71 years (range 25-93). Demographic 
data, peripheral vascular status and history, and total 
risk factor score are summarised in Table 1. The status 
of renal insufficiency status is depicted in Table 2. The 
distribution of the eight arteriosclerosis r k factors as 
classified by the SVS/NA-ISCVS standards i depicted 
in Fig. 1. Perioperative data are listed in Table 3. All 
patients received antibiotic prophylaxis. The graft 
location was partially or predominantly subcutaneous 
in 21 limbs (Group I): 19 vein grafts (17 in situ) and 
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Table 1. Demographic and preoperative data 
Total Group Group p- 
I II value 
Patients 42 20 22 
Male : female 28:14 13:7 15:7 NS 
Median age 71.0 76.5 68.5 NS 
mean (S.E.M.) 69.0 (2.3) 71.3 (3.2) 67.0 (3.3) 
range 25-93 37-93 25-91 
Cases 47 21 26 
Preoperative limb status 
Clinical category 4:5:6* 12:34:1 5:16:0 7:18:1 
Vascular surgical history 
none 32 16 16 
aortoiliac 4 2 2 
Infrainguinal ipsilateral 4 1 3 
Infrainguinal contralateral 14 3 11 
Median total risk score* 9.0 8.0 9.0 NS 
mean (S.E.M.) 8.5 (0.4) 8.5 (0.6) 8.5 (0.5) 
range 4-16 4-16 4-13 
*According to the SVS/NA-ISCVS standards: Cat.4: Ischaemic rest 
pain; Cat.5: Minor tissue loss (nonhealing ulcer, focal gangrene with 
diffuse pedal ischaemia); Cat.6: Major tissue loss: gangrene extending 
above transmetatarsal level. 
*For patients with unknown lipid status (n=20), zero points were 
added to the total risk factor score. 
Table 2. Renal status 
Total Group Group p- 
I II value 
Cases 47 21 26 
Median during CRI, 48 36 54 NS 
(months) range 6-120 6-144 6-144 
Dialysis, AV: CAPD : none 5:3:39 1:2:18 4:1:21 NS 
Renal transplant, yes : no 4:43 0:21 4:22 NS 
lmmunosuppressed medic, 
yes:no 4:43 0:21 4:22 
Presumed renal disease 
unknown 9 5 4 
hypertension 7 5 2 
diabetes 17 8 9 
nephrosclerosis 4 2 2 
cholesterol emboli 5 1 4 
other 5 0 5 
Median creatinine* 3.1 2.9 3.1 NS 
mean mg/dl (S.E.M.) 4.2 (0.4) 4.3 (0.7) 4.0 (0.5) 
range 2.0-14.3 2.0-10.0 2.1-14.3 
*For dialysis patients: before dialysis. 
two composi te  PTFE-vein grafts were used. The 
remain ing 26 grafts were pos i t ioned in the anatomic or 
subfascial p lanes (Group II): 12 vein grafts and 14 
prosthetic grafts (13 PTFE, 1 Dacron). In Group I, 19 of 
the 21 conduits were vein compared  to 12 of the 26 in 
Group II. The distal anastomosis  in 19 of 21 grafts of 
Group I were constructed be low knee, compared  to 16 
of 26 grafts in Group II. 
The surgical site infections are detai led in Table 4. In 
Group  I, seven early, one intermediate,  and one late 
infection were found (9/21, 43%). In three of these 
patients the graft was  exposed and two required graft 
removal .  In contrast, only two early and one inter- 
mediate infection (3/26, 8%) were noted in Group II 
(p = 0.02). In Group I, the thigh incision was  invo lved 
in five of the nine SSI cases, as opposed  to only one 
thigh invo lvement  in Group II. In both groups,  the 
groin incision was  invo lved in three cases. Four 
reoperat ions for infectious compl icat ions were neces- 
sary in Group I compared  to no reoperat ions in Group 
II (p = 0.03). There were four pat ients on immunosup-  
pressive medicat ion after renal t ransplantat ion (Table 
2). These patients all had a deeply  p laced graft and 
were responsible for all three wound infections (two 
deep, one superficial) in the non-subcutaneous  
group. 
Univar iate analysis of the factors also inc luded in 
the logistic regression analysis showed the location of 
the distal anastomosis  and age to be signif icantly 
associated with SSI (Table 5). Twelve possible covari-  
ables to wound heal ing were selected to be included in 
a stepwise logistic regression analysis of the 42 first 
grafts. The only control lable factor signif icantly pre- 
dict ing SSI was  "subcutaneous  location" (relative 
risk = 11.6, p < 0.01). Age (p < 0.01) also mainta ined 
statistical significance, but  the effect of the above knee 
anastomosis  could not be conf i rmed as an independ-  
ent factor. Final parameter  est imates for the logistic 
regression are shown in Table 6. 
P r imary  and secondary patenc)5 and salvage rates 
for all 47 grafts in this s tudy are depicted in Fig. 2. Fig. 
3 gives the overal l  survival  of Group I and II, and 
Diabetes 
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Fig. 1. Individual risk factors by inclusion group. For the eight risk 
factors, the number of patients falling into each severity class is 
given for Group I (Subcutaneous graft position) on the left and for 
Group II (Subsartorial graft position) on the right. The bar patterns 
refer to the severity of risk factors as graded by the SVS/NA-ISCVS 
standards: (~)=Mild (•); (~N)=Moderate (2); (==)=Severe (3); 
(R) = Unknown/Not documented. 
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Table 3. Perioperative data 
Total Group Group p- 
I II value 
Cases 47 21 26 
Graft material, vein :prost. 31:16 19:2 12:14 0.002 
Intraoperative angiogram, yes :no 15:32 8:13 7:19 NS 
Median during surgery (h) 4.5 4.5 4.25 NS 
range 1-10 1-7 1.5-10 
All reoperation, yes :no 13:34 10:11 3:23 0.008 
for infection, yes :no 4:43 4:17 0:26 0.03 
other, yes:no 12:35 6:15 3:23 NS 
Median length of stay (days)* 23 21 25 NS 
range 9-129 9-129 10q54 
Anastomosis: 
femoral to AK # popliteal 12 2 10 0.04 
femoral to BK popliteal 16 8 8 
femoral to tibial 15 7 8 
femoral to pedal 4 3 0 
below knee popliteal to tibial 1 1 0 
*Excluding in-hospital deaths (one in each group). 
*AK: above knee; BK: below knee. 
depicts the expected survival for a similar group of 
individuals from the general population. Comparing 
cumulative survival of patients with and without SSI 
revealed a significant difference: the i year survival of 
patients with SSI was 60% vs. 94% of patients without 
(p = 0.01). 
Discussion 
The purpose of this retrospective study is to inves- 
tigate the possible association between wound infec- 
tions and the subcutaneous graft location following 
infrainguinal revascularisation in patients with CRI. 
The results show that the wound infection rate is 
higher in the group of subcutaneous grafts (Group I, 
9/21 = 43%) as compared to the deeply placed grafts 
(Group II, 3/26 = 12%). This statistically significant 
difference is found despite 90% of the bypasses in 
Group I being vein grafts as opposed to only 46% in 
Group II. It is also remarkable that all three infections 
in Group II were found in patients on immunosup- 
pressive medication for kidney transplants. The exclu- 
sion of these transplanted patients from the study 
would make the difference in infection rate between 
Group I and II even more apparent: 9/21  in Group I = 
42% vs. 0/22 in Group II, p = 0.005). 
Clearly a multitude of cofactors to wound healing 
are in effect. With the intention to confirm or deny the 
independent statistical significance of the factors 
identified in the univariate analysis, a multiple logistic 
regression analysis was performed. This analysis 
confirmed the subcutaneous location as an independ- 
ent factor significantly associated with SSI. Although 
not controllable, age was also shown to be an 
important factor in this respect. Surprisingly, older 
patients had a lower incidence of wound infections, 
with a relative risk of 0.45 per decade. This means, for 
instance, that the risk of developing a wound infection 
in a 70-year-old patient is 0.45 times that of a 60-year- 
old patient. Most likely, the reason for younger 
arteriosclerosis patients being at higher risk of devel- 
oping wound infections is multifactorial. Some of 
these factors may not be included in our logistic 
regression model or may not achieve statistical sig- 
nificance for wound infection as an individual param- 
eter. This point is substantiated by the higher total risk 
factor score in 22 patients of 70 years of age and under 
with a median score (range) of 9.5 (6-16) vs. 7.0 (4-11) 
in 25 patients older than 70 (p = 0.001). In the multi- 
variate analysis, the difference between the number 
grafts in each group with a distal anastomosis above 
the knee did not sustain its univariate statistical 
significance. 
The clinical significance of the results of this study 
may be challenged by interpreting data as follows: 
only six superficial SSI's in the subcutaneous group 
account for the statistically significant difference, and 
all but one SSI were treated by conservative, local 
wound care and antibiotics. Another argument could 
be that despite the higher number of SSI's in Group I, 
no difference could be found in outcome parameters 
such as length of hospital sta3~ limb salvage, and 
mortality. The potential hazards of a wound infection 
should not be underestimated however. A superficial 
SSI is potentially dangerous despite the benign termi- 
nology. CDC definitions require positive cultures, 
purulent discharge from the incision, or sufficient 
symptoms for deliberate opening of the wound. 
Although the SSI may involve no more than the 
superficial layers of the incision, a subcutaneous graft 
is immediately jeopardised by this infection. In the 
presence of a subcutaneous graft, the term superficial 
SSI underestimates the potential severity of the prob- 
lem. Finall3~ wound infections may theoretically have 
devastating consequences in these immunocompro- 
raised patients. Peritonitis, for instance, is a potentially 
lethal complication of a wound infection close to a 
peritoneal dialysis catheter. 
Another aspect of this study is the location of SSI. 
The number of infections of the groin incision was 
equal in Group I and II. This could be anticipated since 
all grafts originated from the deep layers of the groin 
incision. In only one patient both the thigh and the 
groin were involved. Although this is just one obser- 
vation, it demonstrates the potential of thigh infec- 
tions directly contaminating the groin. 
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Table 4. Surgical site infections 
Case Initials SSI level SSI location Subcutaneous Infected Exposed Treatment 
position (Group) graft graft 
WT Superficial Groin Yes (I) No No Local wound care 
EB Superficial Thigh Yes (I) No No Operative debridement 
AH Deep Thigh Yes (I) Yes Yes Graft excision 
IC Superficial Groin Yes (I) No No Bedside debridement 
JS Superficial Knee Yes (I) No No Antibiotics 
HM Superficial Groin/calf Yes (I) No No Local wound care 
CQ Deep Groin No (II) Yes No Opened on floor before 
reoperation 
GF Deep Groin No (II) No No Local wound care 
SW Deep Calf Yes (I) No Yes Operative debridement 
KC Deep Groin/thigh Yes (I) Yes Yes Excision and AKA* 
DH Superficial Thigh Yes (I) No No Antibiotics 
HN Superficial Thigh No (II) No No Antibiotics 
* AKA: above knee amputation. 
Table 5. Uni- and multivariate analysis 
Variable Condition SSI No SSI Univariate* Multivariate  
(N=12) (N=35) p-value p-value 
Immunosuppression Yes 2 1 0.16 0.06 
Distal anastomosis Above knee 0 12 0.02 0.11 
Male Yes 6 27 0.29 0.17 
Creatinine (3.6)$ (4.3) 0.52 0.27 
Coronary disease Yes 1 8 0.41 0.31 
Ulceration/gangrene Yes 10 22 0.28 0.35 
Duration of operation (4.5) (4.6) 0.83 0.67 
Diabetes Yes 9 22 0.50 0.78 
Vein graft Yes 10 21 0.18 0.80 
Total risk score (7.0) (6.6) 0.77 0.95 
Age (60.5) (73.2) 0.04 
Age <60 5 2 0.01 
Subcutaneous graft Yes 9 12 0.02 
*Numerical variables are tested using the Mann-Whitney test, binomial variables with the Fisher Exact est. 
~Residual values of variables not in the final logistic regression analysis equation. The variable that are included in the final equation are listed 
in Table 6. Only the first grafts in bilateral patients are entered in the multivariate analysis. 
SMean for numerical variables within parenthesis. 
Table 6. Variables in the logistic regression analysis equation 
Variable Relative risk p-value 
Subcutaneous graft 11.6 if yes 0.01 
Age 0.45 per decade 0.01 
Constant 0.12 
It could be argued that only four extra thigh 
infections in subcutaneous group are responsible for 
the difference in SSI-rate between Group I and II. 
However,  two of the thigh SSI's were deep infections, 
requir ing excision and above knee amputat ion in one 
patient and operative debr idement  in the other. Only  
one of these four patients could be treated with local 
wound care and antibiotics. 
Also, our venous bypass technique may play a role: 
it involves a full exposure of the saphenous vein using 
one longitudinal  incision, for both the in situ bypass 
and for vein harvesting. In centres try ing to use 
smaller incisions, the difference in wound infection 
rates may be less evident. 
As an inevitable result of fo l lowing the strict CDC 
criteria for wound infections, the overall infection rate 
in the present study is high (12/47= 26%). Another  
contr ibutory factor to this is the decreased cell- 
mediated immuni ty  and increased infection suscepti- 
bil ity of uremic pat ients J  2 The number  of graft 
infections (3 /47= 6%) is similar to that in collated 
series. 13 
In try ing to explain the difference in infection rate 
between subcutaneously  and deeply placed grafts, it 
must  be realised that all l imb incisions disrupt 
lymphat ic  f low and drainage. However,  subcuta- 
neously placed grafts could impair  wound heal ing 
even further when compared to vein harvest and 
subfascial p lacement of grafts. 
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From six similar reports, 14 describing 275 bypasses 
in 222 CRI-patients we calculated the weighted aver- 
ages and 95% confidence limits of fo l low-up data at 2 
years. The pr imary  patency rate was 75% (70%-80%), 
the salvage rate 82% (77%-86%), and the survival rate 
53% (46%-59%). We found a similar 2 year pr imary  
patency rate (77%) and salvage rate (76%), but our 
overall 2 year survival  rate (79%) was higher com- 
pared to the collated series. Thus, in agreement with 
earlier reports, 2'5 our fo l low-up data do not support  a 
pessimistic v iewpoint  toward  infrainguinal revascu- 
larisation in patients with CRI. A l though statistical 
significance is reached for the difference in survival  
between the patients with an SSI (1 year sur- 
v ival- -60%) and those wi thout  (1 year sur- 
vival = 94%), there are just 12 patients in the infection 
group and many other covariables may influence 
these survival data. Numbers  are therefore too small 
for a val id mult ivariate survival analysis of these data. 
However,  factors responsible for an increased wound 
infection rate may essentially be the same as those 
leading to an increased mortal i ty rate. 
Though mult ivariate statistical analysis appears to 
confirm the independent  association between the 
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Fig. 2. Cumulative primary and secondary patency and limb salvage rates for all 47 limbs. ( i ) :  Primary patency; (
patency; (- - -): Limb salvage. 
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Fig. 3. Cumulative overall patient survival by inclusion group. ( I ) :  Group I (Subcutaneous graft position, n=20); ( ): Group II 
(Subsartorial graft position, n = 22); (- - -): Expected survival of 42 similar individuals from the general population, matched for age and 
sex .  
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subcutaneous graft location and SSI, a prospective 
randomized  study seems inevitable to preclude selec- 
t ion bias. Establishing a difference as found in this 
retrospective study ( + 40% vs. + 10%) with a power  of 
80%, requires 30 patients in each study arm. This will 
yield 95% confidence limits for the main effects of 
25%-58% for Group I and 4-26% for Group II. Because 
in the Massachusetts General Hospital  we found only 
three eligible patients per year, this wou ld  involve a 
multicentre effort. Until further prospective data are 
available, we wou ld  recommend avoid ing subcuta- 
neous placement of an infrainguinal bypass graft in 
patients with CRI. 
Conclusions 
We conclude that the infrainguinal bypass in patients 
with CRI is associated with a high incidence of wound 
complications. In this retrospective series, the pres- 
ence of a vascular conduit  in the subcutaneous plane 
was connected with a higher risk of SSI. Deeply  placed 
grafts were associated with an infection rate similar to 
that in the general populat ion.  Despite the growing 
trend toward  the use of the in situ bypass, CRI may 
represent a circumstance where deeply placed grafts 
should be used preferentially. 
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